Zhitong Finance App News, Hebang Biotech (603077.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 4.522 billion yuan, a year-on-year decrease of 23.70%; net profit attributable to shareholders of listed companies was 454 million yuan, an increase of 387.48%; after deducting non-net profit of 447 million yuan, a year-on-year increase of 398.60%; and basic earnings per share were 0.0554 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.